| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |